Selective depletion of the allo-antigen specific T cells by Fas/FasL pathway by cytokine IFN-gamma and IL-2.
- Author:
Juan XIAO
1
;
Ping ZOU
;
Zhongwen LIU
;
Lingbo LIU
;
Zhongbo HU
Author Information
1. The Institute of Hematology, Xiehe Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan, 430022.
- Publication Type:Journal Article
- MeSH:
Antigens, CD34;
biosynthesis;
immunology;
Apoptosis;
Cytotoxicity, Immunologic;
DNA, Complementary;
genetics;
Fas Ligand Protein;
Graft vs Host Disease;
prevention & control;
Interferon-gamma;
biosynthesis;
immunology;
Interleukin-2;
biosynthesis;
immunology;
Membrane Glycoproteins;
biosynthesis;
immunology;
T-Lymphocytes;
cytology;
physiology;
fas Receptor;
biosynthesis;
immunology
- From:
Journal of Huazhong University of Science and Technology (Medical Sciences)
2003;23(4):344-347
- CountryChina
- Language:English
-
Abstract:
To investigate the value of apoptosis of the allo-antigen specific T cells induced by Fas/FasL pathway in preventing graft-versus-host disease (GVHD), the CD34+ cells transfected with FasL or not, used as stimulus cells, were mixed with allo-antigen specific T lymphocytes in presence or absence of IFN-gamma and IL-2. After 5 days, apoptosis of T cells was detected by TdT nick end mediated dUTP labeling (TUNEL) and flow cytometry (FCM). The affects of these two cytokines on CD34+ cells in the graft were also compared. The ratio of apoptosis of T cells was 12.1+/-1.5% when CD34+ cells transfected with FasL was used as stimulus cells, much higher than that of CD34+ cells non-transfected (3.2+/-1.1%, P<0.01). And in presence of IFN-gamma or IL-2, the ratio reached 20.1+/-2.3%, 17.6+/-1.3% respectively (P<0.01). However, IFN-gamma up-regulated Fas expression of CD34+ cells and increased the sensibility of CD34+ cells to soluble FasL (sFasL); IL-2 showed no such effect. It is possible to induce apoptosis of the allo-antigen specific T cells of grafts activated by allo-antigen by exogenous Fas ligand expressed on recipient cells and this might provide a new approach for preventing GVHD and IL-2 may be more suitable for clinical application.
